The Filing Desk

BGM Group vs Nanobiotix

BGM Group BGM · Nanobiotix NBTX · Pharmaceuticals

BGM Group reported revenue of $38 million in fiscal 2025, and Nanobiotix €33 million in fiscal 2025, in different currencies. BGM Group had an operating margin of -33.2%, against -33.2% at Nanobiotix. Free cash flow was −$4 million at BGM Group and −€34 million at Nanobiotix. Their fiscal years end in different months (September 30 and December 31), so the periods don't line up exactly.

Side by side

BGM GroupNanobiotix
Latest fiscal yearFY2025, Sep 30, 2025FY2025, Dec 31, 2025
Revenue$38M€33M
Revenue growth51.1%—
Revenue growth a year, last 5 years−5.4%67.1%
Gross margin16.6%—
Operating margin−33.2%−33.2%
Net margin−52.6%−73.5%
Free cash flow−$4M−€34M
Free cash flow margin−10.4%−104.2%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M€0M
Change in diluted share count1,467.3%1.2%
Last close$8.00$27.32
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
In each company's own currency, fiscal years
BGM GroupNanobiotix
Operating margin
Percent of revenue
BGM GroupNanobiotix
Free cash flow
In each company's own currency. Cash from operations minus capital expenditure.
BGM GroupNanobiotix

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the BGM Group and Nanobiotix pages.